Borrelien IgM ELISA/人包柔氏螺旋体IgM抗体ELISA检测试剂盒

原厂品牌:BIOMEDICA

规格选择
货号规格目录价货期
BI-2104212 x 8 tests¥4,6903~4周

产品详情

Lyme borreliosis is a bacterial infection caused by the spirochete Borrelia Burgdorferi, Borrelia Afzelii and Borrelia Garinii and is the most vector-transmitted human disease in Europe. The spirochetal bacteria were first described and isolated in 1981 by Willi Burgdorfer in the tick Ixodes dammini in Montana (USA). The infection with Borrelia is characterized by a variety of clinical symptoms and can be divided into 3 stages: Stage 1, early dermatitis, appearing days or weeks after the infection. Clinical: erythema migrans. Stage 2, early disseminated infection, appears weeks to months after infection. Clinical: lymphocytic meningoradiculitis (Bannwarth's syndrome), neuroborreliosis. Stage 3, late disseminated infection, occurring up to years after infection. Clinical: chronic progressive encephalomyelitis, acrodermatitis chronica atrophicans (ACA), chronic arthritis. Antibiotic therapy is indicated in all stages of the disease. It shortens disease duration significantly, when instituted in stage 1. Diagnosis of the bacterial infection relies on the detection of specific IgM antibodies against Borrelia. To ensure diagnostic specificity, the Borrelia IgM ELISA microwell strips are coated with the following Borellia-specific recombinant antigens: p21 = OspC (outer surface protein C): B. afzellii (pKo), B. garinii (20047) p41/I = (inner part of flagellin): B. bavariensis (pBi) VIsE: fusion proteins of different Borrelia genospecies Many features of later infection are not specific to Lyme Borreliosis and occur in other conditions. The diagnosis of Lyme Borreliosis should be made only after careful evaluation of the patient´s clinical history, physical findings, laboratory evidence and exposure risk evaluation.
共 0 条

暂无评价

本网站所展示所有内容(包括所销售产品),仅限于RUO(科学研究使用范畴);只可用于科研或工业等非医疗目的,不得用于人类或动物临床实验、诊断或治疗等医疗目的。
Copyright © 2026 GTG 青木生物技术(武汉)有限公司版权所有鄂公网安备 42011102003626号备案号:鄂ICP备15014906号-1